Fortis Healthcare Ltd

Fortis Healthcare Ltd

₹ 915 -0.80%
28 Nov 2:28 p.m.
About

FHL was incorporated in February 1996. The company’s first healthcare facility became operational in Mohali, Punjab in 2001. It is a leading integrated healthcare service provider in India. The healthcare verticals of the company primarily comprise hospitals, diagnostics and day care specialty facilities. Currently, the company operates its healthcare delivery services in India, Nepal, Dubai and Sri Lanka with 36 healthcare facilities with approximately 4,000 operational beds. [1]

Company controls its diagnostics business through its 57% owned subsidiary SRL Limited. It is amongst the largest private diagnostics chains. It has a presence in over 600 cities and towns, with an established strength of 415 laboratories, 8,200 direct clients and 1,400 Collection Centers. [2]

Key Points

Business Segments [1]
a) Hospital Segment: Co. operates Multi-specialty and super-speciality hospitals providing inpatient and outpatient treatments across various disciplines.

  • Market Cap 69,052 Cr.
  • Current Price 915
  • High / Low 1,105 / 521
  • Stock P/E 373
  • Book Value 122
  • Dividend Yield 0.11 %
  • ROCE 3.27 %
  • ROE 1.41 %
  • Face Value 10.0

Pros

  • Company has been maintaining a healthy dividend payout of 78.2%

Cons

  • Stock is trading at 7.59 times its book value
  • Company has a low return on equity of 1.13% over last 3 years.
  • Earnings include an other income of Rs.183 Cr.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
266 262 277 289 294 291 307 333 357 367 388 433 456
228 226 250 254 255 242 238 275 297 300 318 345 356
Operating Profit 38 36 28 35 40 49 69 58 60 67 71 88 100
OPM % 14% 14% 10% 12% 13% 17% 23% 17% 17% 18% 18% 20% 22%
106 42 30 31 110 32 65 35 36 40 -27 57 114
Interest 28 25 25 23 21 19 18 17 16 27 52 52 51
Depreciation 29 29 29 25 25 25 26 26 27 29 31 30 28
Profit before tax 87 24 3 18 104 36 90 50 52 51 -39 63 135
Tax % 5% 18% 41% 27% 8% 36% 24% 47% 24% 22% 9% 18% 7%
82 19 2 13 95 23 68 27 40 40 -42 52 125
EPS in Rs 1.09 0.26 0.03 0.17 1.26 0.30 0.91 0.36 0.52 0.52 -0.56 0.69 1.66
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
369 611 612 645 659 656 702 633 863 1,053 1,181 1,446 1,644
449 758 737 792 697 780 633 605 747 919 988 1,190 1,318
Operating Profit -80 -148 -125 -146 -38 -123 69 28 116 134 193 256 326
OPM % -22% -24% -20% -23% -6% -19% 10% 4% 13% 13% 16% 18% 20%
229 220 166 165 70 522 809 248 118 197 236 83 183
Interest 91 81 65 106 64 192 160 141 130 106 82 112 181
Depreciation 17 27 25 27 29 27 97 111 113 116 101 113 118
Profit before tax 41 -36 -50 -114 -60 180 621 24 -9 109 247 114 210
Tax % 42% -5% -19% -34% 6% 31% 17% 83% 48% 12% 19% 44%
24 -34 -40 -75 -64 123 513 4 -13 96 199 64 174
EPS in Rs 0.52 -0.73 -0.87 -1.44 -1.23 1.63 6.80 0.06 -0.18 1.27 2.64 0.84 2.31
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 78% 38% 118%
Compounded Sales Growth
10 Years: 9%
5 Years: 16%
3 Years: 19%
TTM: 28%
Compounded Profit Growth
10 Years: 16%
5 Years: -27%
3 Years: 157%
TTM: -2%
Stock Price CAGR
10 Years: 19%
5 Years: 44%
3 Years: 46%
1 Year: 42%
Return on Equity
10 Years: 1%
5 Years: 1%
3 Years: 1%
Last Year: 1%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Sep 2025
Equity Capital 463 463 463 518 519 755 755 755 755 755 755 755 755
Reserves 3,247 3,217 3,284 3,754 3,708 7,608 8,122 8,127 8,114 8,209 8,332 8,319 8,420
1,279 1,234 1,076 647 555 1,478 1,361 1,380 1,193 785 659 2,039 2,030
171 246 215 242 234 279 343 320 365 620 640 887 780
Total Liabilities 5,160 5,159 5,039 5,161 5,016 10,120 10,581 10,582 10,426 10,369 10,387 11,999 11,985
146 190 172 186 203 180 906 853 770 492 467 925 1,299
CWIP 121 169 182 199 166 165 33 7 6 3 260 42 55
Investments 2,795 2,411 2,428 3,603 3,658 8,310 8,153 8,898 8,845 8,848 8,834 10,178 10,110
2,097 2,389 2,257 1,174 989 1,466 1,489 824 804 1,027 825 853 521
Total Assets 5,160 5,159 5,039 5,161 5,016 10,120 10,581 10,582 10,426 10,369 10,387 11,999 11,985

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
-45 -144 -761 22 -15 -61 100 32 76 198 218 334
-521 294 394 -72 245 -4,688 810 28 238 205 44 -1,572
484 -170 370 45 -292 4,792 -972 6 -320 -395 -245 1,276
Net Cash Flow -82 -20 3 -5 -62 43 -62 66 -6 8 18 38

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 86 57 61 43 39 47 42 37 32 34 41 46
Inventory Days 16 18 15 14 19 17 25 21 25 18 15 16
Days Payable 172 240 289 340 392 542 525 520 494 572 608 643
Cash Conversion Cycle -70 -165 -213 -284 -334 -479 -457 -462 -438 -520 -553 -581
Working Capital Days 1,283 354 -168 -206 -130 -594 -59 -52 -25 -24 -74 -165
ROCE % 3% 0% 1% -0% 1% 5% 9% 1% 1% 2% 2% 3%

Shareholding Pattern

Numbers in percentages

8 Recently
Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025
31.17% 31.17% 31.17% 31.17% 31.17% 31.17% 31.17% 31.17% 31.17% 31.17% 31.17% 31.17%
31.01% 31.22% 30.03% 26.31% 23.72% 23.24% 23.31% 25.26% 26.77% 27.40% 27.18% 27.90%
20.38% 20.69% 22.17% 26.55% 29.42% 31.14% 32.31% 30.73% 30.05% 29.46% 29.79% 29.14%
17.44% 16.92% 16.65% 15.97% 15.71% 14.44% 13.22% 12.83% 12.02% 11.98% 11.87% 11.79%
No. of Shareholders 1,43,5191,37,8941,35,0471,31,5161,35,6641,57,1651,54,2602,04,1842,21,7502,18,3292,05,3732,20,766

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Concalls